Hyaluronic Acid Viscosupplementation – Market Insights – Global
The HA viscosupplementation market was negatively impacted during the COVID-19 pandemic due to the postponement of elective treatments. Nevertheless, with the easing of restrictions and the increase in vaccination rates, the market has shown signs of recovery. Factors such as favorable demographics, increased patient awareness, improved physician training, effective marketing efforts by companies, and ongoing product innovation will contribute to the modest growth of the HA viscosupplementation market. Furthermore, premium-priced 1-injection products will continue to become more popular over the forecast period, whereas 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for HA viscosupplementation in the US, Europe, Asia Pacific, and Brazil from 2019 through 2032.
The HA viscosupplementation market will be driven by the continuous introduction of 1-injection and other indication expansion.
How will the introduction of new products with more clinical data supporting the efficacy of HA treatment affect procedure volumes?
How fast are different geographies moving toward shorter treatment regimens, and how will the adoption of 1-injection products impact the market in the upcoming years?
What impact will the transition toward the 1-injection market have on the multi-injection market throughout the forecast period?
Reimbursement for HA injections in Europe is facing scrutiny.
Which countries have limited or a complete lack of reimbursement for these products?
In the absence of reimbursement, what are the strategies companies use to promote their products?
In the Asia Pacific region, domestic manufacturers have gained popularity.
What are the factors influencing HA viscosupplementation product adoption among these competitors?
How are domestic manufacturers’ product offerings evolving?
How are the domestic companies effected by the government initiatives?
Which countries have domestic companies with particularly high market shares, and what factors contribute to their dominance?
Table of contents
- Hyaluronic Acid Viscosupplementation - Market Insights - Global
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Global Hyaluronic Acid Viscosupplementation Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- HA Viscosupplementation Treatments, by Region, Global, 2019u20132032
- HA Viscosupplementation Treatments, by Anatomy, Global, 2019u20132032
- HA Viscosupplementation Market, by Region, Global (USD), 2019u20132032
- HA Viscosupplementation Market, by Number of Injections, Global (USD), 2019u20132032
- HA Viscosupplementation Market Growth, by Number of Injections, Global, 2020u20132032
- Market Shares
- Competitive Insights
- Market Developments
- US Hyaluronic Acid Viscosupplementation Market
- European Hyaluronic Acid Viscosupplementation Market
- Asia Pacific Hyaluronic Acid Viscosupplementation Market
- Brazilian Hyaluronic Acid Viscosupplementation Market
- Appendix
Vidisha Mittal is an associate healthcare research and data analyst within the Orthopedic, Dental and Aesthetics Medtech Insights team at Clarivate, focusing on the large-joint reconstructive implant market. Vidisha holds a Master’s degree in Biotechnology from Amity University, Noida.